Registrants of veterinary medicines can now have their products reviewed by Australian and UK regulators at the same time.
In a move that will facilitate speedier reviews, the Australian Pesticides and Veterinary Medicines Authority (APVMA) and the United Kingdom Veterinary Medicines Directorate (VMD) have developed a guidance that will serve as the foundation for simultaneous reviews of veterinary medicine submissions.
Dr Melissa McEwen, Acting Chief Executive Officer at APVMA, said this exciting new approach can reduce the burden and provide the opportunity for a single project team to work on the application in line with common assessment timeframes.
“The guidance supports the APVMA and VMD’s shared aim of expanding access to treatment options for animals and helping food producers stay competitive globally.
“The guidance outlines how the simultaneous review process will work and is intended to complement each country’s legislative and regulatory framework and associated technical guidelines, which remain in place.
“The APVMA is excited by the opportunity to streamline the registration process, and we look forward to working with the VMD and veterinary stakeholders on this new initiative.”
To stay up to date on the latest industry headlines, sign up to the Pet Industry News e-newsletter.